Skip to main content

Table 1 Dynamic changes in alpha-fetoprotein (AFP) level of the patient with advanced hepatocellular carcinoma before and after sorafenib treatment

From: Case analysis of complete remission of advanced hepatocellular carcinoma achieved with sorafenib

Detection time

Detection method

AFP (ng/ml)

Assessment

2010.10.25

Chemiluminescence

51750.00

Normal range, 0–20 ng/ml

2010.11.29

Chemiluminescence

21668.00

Decrease by >50% in week 5

2011.02.16

Chemiluminescence

54.33

Close to normal in week 15

2011.04.14

Chemiluminescence

<10

Normal in week 23

2011.05.18–13.11.12

Chemiluminescence

<10

Normal for >30 months